Authors



Bob Lomenick, RPh

Latest:

The Business Case: Formal Adherence Service in the Community Pharmacy

A business model focused on medication synchronization can boost adherence and profits.


Christopher Casale RPh, BA, BS, AAHIVS

Latest:

Going Above and Beyond as Pharmacists

Learn more about what it's like to work for a Walgreens specialty pharmacy.



Amy J. Guisinger, PharmD/MPH Candidate

Latest:

Emerging Therapies for Hemophilia A and B

Although the leading treatment for hemophilia is a replacement therapy in the form of both plasma-derived and rF products, research is underway for the discovery of novel agents.


Jennifer A. Reinhold, PharmD, BCPS, BCPP

Latest:

Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in Insomnia

This Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.


Anthony Luparello, PharmD Candidate

Latest:

A Closer Look at New FDA Actions: Amgen's Prolia

Amgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.


Kevin J. Lynch, PharmD, BCPS, MBA

Latest:

Implementation Strategy to Bring Medication Therapy Management Into High-­Volume Community Pharmacies

This study shows how medication therapy management can be integrated into challenging pharmacy work flow, and also assesses the resulting benefits, both clinical and financial.


BPharm

Latest:

Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs

The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.


Kelly T. Custer, Esq

Latest:

HHS Issues Much Anticipated Updates to Provider Relief Fund Deadlines and Reporting Requirements

Pharmacies that received more than $750,000 in federal funds, including funds from the CARES Act Provider Relief Fund, will be subject to single audit requirements.


Winghan Jacqueline Kwong, PharmD, PhD

Latest:

Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients

An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.


Steve Stricker, PharmD, MS, BCOP

Latest:

Managing Cancer Pain: Therapy Should Be Tailored to Each Patient

The pharmacist's role can be integral to adequate cancer pain relief and a return of quality of life.


Vinay Sawant, RPh, MPH, MBA

Latest:

Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19

The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.


Jane Giang, PharmD, BCPS, CGP

Latest:

Hepatitis C: New Treatment Guidelines

Hepatitis C treatment guidelines have been updated to include several new drugs.


Marcela A. Saenz

Latest:

Optimization of Biopharmaceuticals

Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.



Joette Gdovin Bergeson, PhD

Latest:

US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus

Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.



Virginia Bartok, RPh

Latest:

Myocardial Infarction, Blood Sugar, and Diabetes: Treatment After Discharge

Medication omission at discharge is the most common type of medication discrepancy.


Richard Engleka, Regional Operations Director at Walgreens

Latest:

Industry Takeaways From Asembia

As it is every year, the Asembia Summit was filled with a plethora of information that allowed for networking, business development, and personal development.


Amy M. Egras, PharmD, BCPS

Latest:

Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide

Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.


Anthony Palmieri, RPh, MBA

Latest:

Generic Drug Trends in the United States

By 2012, we estimate that more than 3 of every 4 prescriptions will be filled with a generic drug.


Kathleen M. Vest, PharmD, CDE, BCACP

Latest:

Addressing Immunizations in Pregnant and Lactating Women

The immunization status of pregnant and lactating women should be routinely assessed, and indicated vaccines should be recommended.


Jessica Smith, Assistant Editor

Latest:

Innovative Pharmacy Caters Solely to Women

A women's pharmacy that opened last week in Vancouver is the first of its kind in North America. More than a pharmacy, Lu's: A Pharmacy for Women offers everything from private counseling areas and a resource library to support groups and other women-centric programs.


Laressa Bethishou, PharmD, BCPS

Latest:

Pneumonia Vaccines: Current Recommendations and Advocacy Opportunities

Pneumonia is a bacterial, viral, or fungal infection of the lungs that can be mild to severe in presentation.



Joanne Canedo, PharmD Candidate

Latest:

Tip of the Week: Strategic Planning for Pharmacy Emergency Preparedness and Response Activities

Pharmacy organizations have produced advisories to guide workflow and optimize services, yet there still exists a gap in further integration of pharmacists into public health and safety initiatives.


Sharon J. Rolnick, PhD, MPH

Latest:

Barriers to and Facilitators of Medication Adherence

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.


Jena Ivey Burkhart, PharmD, BCPS, CPP

Latest:

JNC 8 and Older Adults: A Review of the Evidence

New Guideline for Blood Pressure Management in Older Patients